ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-05-20–present
Board Member
Zoetis Inc. (ZTS)Equibles does not estimate personal net worth.
Get an email with a short summary when Zoetis Inc. publishes a filing, an earnings call transcript or a press release.
Get ZTS alertsMichael B. McCallister is recorded as Board Member at Zoetis Inc. (ZTS) since May 20, 2026. Zoetis Inc. reported in an 8-K filed May 22, 2026 that Michael B. McCallister was appointed director, effective May 20, 2026. Michael B. McCallister has spoken on 2 investor events across 1 company, most recently for Zoetis Inc. on May 20, 2026. Zoetis Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Zoetis Inc. includes Juan Ramón Alaix (CEO), James (Jay) Saccaro (CFO), James Saccaro (CFO and COO) and 7 others.
“Each of the twelve nominees for director was elected to serve for a one-year term until the 2027 Annual Meeting of Shareholders or until each director's successor has been elected and qualified, or until such director's earlier death, resignation or removal.”
“I'm Mike McAllister, Chair of the Board, and I'd like to thank you for your interest in our company and welcome to you to our virtual shareholder meeting. At this time, I'd like to introduce the other board members who are participating in today's meeting.”
“I'm Mike McAllister, Chair of the Board, and I'd like to thank you for your interest in our company and welcome to you to our virtual shareholder meeting. At this time, I'd like to introduce the other board members who are participating in today's meeting.”
2026-05-20–present
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-05-20–present